Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 856 AL 870

Criteria for identification of advanced Parkinson's disease: the results of the Italian subgroup of OBSERVE-PD observational study

Stefani A, Tessitore A, Tambasco N, Cossu G, Ceravolo MG, Defazio G, Morgante F, Ramat S, Melzi G, Gualberti G, Merolla R, Onuk K, Lopiano L.

BMC Neurol. 2022 Jan 28;22(1):41. doi: 10.1186/s12883-022-02554-z.

Uncoupling proteins as a therapeutic target for the development of new era drugs against neurodegenerative disorder

Kumar R, T A, Singothu S, Singh SB, Bhandari V.

Biomed Pharmacother. 2022 Mar;147:112656. doi: 10.1016/j.biopha.2022.112656. Epub 2022 Jan 25.

Effects of dance therapy on non-motor symptoms in patients with Parkinson's disease: a systematic review and meta-analysis

Wang LL, Sun CJ, Wang Y, Zhan TT, Yuan J, Niu CY, Yang J, Huang S, Cheng L.

Aging Clin Exp Res. 2022 Jun;34(6):1201-1208. doi: 10.1007/s40520-021-02030-7. Epub 2022 Jan 29.

The interplay between oxidative stress and autophagy: focus on the development of neurological diseases

Talebi M, Mohammadi Vadoud SA, Haratian A, Talebi M, Farkhondeh T, Pourbagher-Shahri AM, Samarghandian S.

Behav Brain Funct. 2022 Jan 29;18(1):3. doi: 10.1186/s12993-022-00187-3.

Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy

Korb M, Peck A, Alfano LN, Berger KI, James MK, Ghoshal N, Healzer E, Henchcliffe C, Khan S, Mammen PPA, Patel S, Pfeffer G, Ralston SH, Roy B, Seeley WW, Swenson A, Mozaffar T, Weihl C, Kimonis V; VCP Standards of Care Working Group.

Orphanet J Rare Dis. 2022 Jan 29;17(1):23. doi: 10.1186/s13023-022-02172-5.

Establishing gene regulatory networks from Parkinson's disease risk loci

Farrow SL, Schierding W, Gokuladhas S, Golovina E, Fadason T, Cooper AA, O'Sullivan JM.

Brain. 2022 Jul 29;145(7):2422-2435. doi: 10.1093/brain/awac022.

Intervertebral bridging ossification after kyphoplasty in a Parkinson's patient with Kummell's disease: A case report

Li J, Liu Y, Peng L, Liu J, Cao ZD, He M.

World J Clin Cases. 2022 Jan 14;10(2):677-684. doi: 10.12998/wjcc.v10.i2.677.

Effects of cognitive rehabilitation in Parkinson disease: a meta-analysis

Giustiniani A, Maistrello L, Danesin L, Rigon E, Burgio F.

Neurol Sci. 2022 Apr;43(4):2323-2337. doi: 10.1007/s10072-021-05772-4. Epub 2022 Jan 31.

Novel approaches for quantifying beta synchrony in Parkinson's disease

Karekal A, Miocinovic S, Swann NC.

Exp Brain Res. 2022 Apr;240(4):991-1004. doi: 10.1007/s00221-022-06308-8. Epub 2022 Jan 31.

LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease

Pang SY, Lo RCN, Ho PW, Liu HF, Chang EES, Leung CT, Malki Y, Choi ZY, Wong WY, Kung MH, Ramsden DB, Ho SL.

Transl Neurodegener. 2022 Jan 31;11(1):5. doi: 10.1186/s40035-022-00281-6.

Trazodone-induced parkinsonism: A case report

Sharma KD, Colangelo T, Mills A.

Int J Clin Pharmacol Ther. 2022 Apr;60(4):184-187. doi: 10.5414/CP204068.

Roles of humanin and derivatives on the pathology of neurodegenerative diseases and cognition

Thiankhaw K, Chattipakorn K, Chattipakorn SC, Chattipakorn N.

Biochim Biophys Acta Gen Subj. 2022 Apr;1866(4):130097. doi: 10.1016/j.bbagen.2022.130097. Epub 2022 Jan 31.

Stem Cell-based and Advanced Therapeutic Modalities for Parkinson's Disease: A Risk-effectiveness Patient-centered Analysis

Salahi S, Mousavi MA, Azizi G, Hossein-Khannazer N, Vosough M.

Curr Neuropharmacol. 2022 Nov 15;20(12):2320-2345. doi: 10.2174/1570159X20666220201100238.

Study protocol: randomised controlled hybrid type 2 trial evaluating the scale-up of two arts interventions for postnatal depression and Parkinson's disease

Soukup T, Davis RE, Baldellou Lopez M, Healey A, Estevao C, Fancourt D, Dazzan P, Pariante C, Dye H, Osborn T, Bind R, Sawyer K, Rebecchini L, Hazelgrove K, Burton A, Manoharan M, Perkins R, Podlewska A, Chaudhuri R, Derbyshire-Fox F, Hartley A, Woods A, Crane N, Bakolis I, Sevdalis N.

BMJ Open. 2022 Feb 1;12(2):e055691. doi: 10.1136/bmjopen-2021-055691.

Inhibitory activities of grape bioactive compounds against enzymes linked with human diseases

Dwibedi V, Jain S, Singhal D, Mittal A, Rath SK, Saxena S.

Appl Microbiol Biotechnol. 2022 Feb;106(4):1399-1417. doi: 10.1007/s00253-022-11801-9. Epub 2022 Feb 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias